Compare Devon Energy Corp (DVN) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Devon Energy Corp vs Twist Bioscience Corp — how do they compare? Devon Energy Corp trades at $43.15 (market cap $49.52B), while Twist Bioscience Corp trades at $89.45 (market cap $5.76B). The key difference: Devon Energy Corp is far larger — about 8.6× Twist Bioscience Corp's market cap, and Devon Energy Corp pays a 2.42% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| DVN | TWST | |
|---|---|---|
Market Cap | $49.52B | $5.76B |
Sector | Energy | Health |
52-Week High | $52.07 | $102.88 |
52-Week Low | $31.74 | $24.16 |
Enterprise Value | $56.29B | $5.69B |
Dividend Yield | 2.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $43.35, down 0.12% on the day, with a neutral technical signal and bullish moving averages. The stock shows strong fundamentals with a P/E of 11.96, net income margin of 13.71%, and consistent cash flow generation. Recent news highlights activist pressure for asset sales and the integration benefits from the Coterra acquisition, targeting $2 billion in synergies by 2027.
DVN presents a compelling value opportunity with analyst consensus bullish (71% buy ratings) and a price target of $60.18, implying 39% upside. Risks include volatile energy prices, execution of merger synergies, and activist investor demands. Earnings growth and free cash flow remain key catalysts for shareholder returns.
Twist Bioscience (TWST) trades at $90.33, down 2.46% on the day, with a bullish technical outlook despite recent earnings misses. The company shows strong revenue growth from $204M in 2022 to $377M in 2025, though it remains unprofitable with a -19.85% net margin. Analyst sentiment is positive with 11 buy ratings and a $91.63 consensus target, while recent news highlights AI collaborations and upcoming Q3 earnings.
TWST presents a growth story with improving margins and AI-driven demand, but profitability concerns and consistent cash burn pose risks. The stock trades near analyst targets, suggesting limited near-term upside without earnings acceleration. Key catalysts include Q3 results on August 3, 2026, and execution on path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
